182 related articles for article (PubMed ID: 24907951)
1. Detection of abnormal cervical cytology in papanicolaou smears in a tertiary care center.
Hirachand S; Bajracharya J; Pradhanang S; Lama S
JNMA J Nepal Med Assoc; 2013; 52(191):462-5. PubMed ID: 24907951
[TBL] [Abstract][Full Text] [Related]
2. Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method.
Tawfik O; Davis M; Dillon S; Tawfik L; Diaz FJ; Amin K; Fan F
Acta Cytol; 2015; 59(2):187-200. PubMed ID: 25967603
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
Nieh S; Chen SF; Chu TY; Lai HC; Fu E
Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
5. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
6. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
[TBL] [Abstract][Full Text] [Related]
7. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
8. Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India.
Kulkarni PR; Rani H; Vimalambike MG; Ravishankar S
Asian Pac J Cancer Prev; 2013; 14(9):5101-5. PubMed ID: 24175783
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pre-malignant cervical lesions in females presenting with abnormal pelvic complaints.
Tahir QA; Bukhari MH
J Pak Med Assoc; 2020 Feb; 70(2):272-275. PubMed ID: 32063620
[TBL] [Abstract][Full Text] [Related]
10. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
[TBL] [Abstract][Full Text] [Related]
11. [The Pap test in HIV-positive women].
Carlucci M; Cimmino A; Fiore MG; Lepera A; Tantimonaco L; Ricco R
Pathologica; 2001 Dec; 93(6):651-3. PubMed ID: 11785116
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of atypical squamous cells of undetermined significance: a laboratory audit of cervical reporting.
Roche DH; Spicer N
N Z Med J; 2001 Feb; 114(1126):64-6. PubMed ID: 11280428
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of atypical glandular cells in cervical Papanicolaou smears.
Lojindarat S; Luengmettakul J; Puangsa-Art S
J Med Assoc Thai; 2012 Aug; 95(8):975-82. PubMed ID: 23061299
[TBL] [Abstract][Full Text] [Related]
14. Quality metrics in cervical cytopathology: A single institutional study.
Senthil Kumar D; Ravikumar G
Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
[TBL] [Abstract][Full Text] [Related]
15. Cervical Papanicolaou Smear Test Screening among Patients Visiting the Outpatient Department of Gynaecology of a Tertiary Care Centre.
Sapkota RP; Pokhrel S; Bhandari A; Adhikari P; Shrestha M
JNMA J Nepal Med Assoc; 2023 Sep; 61(265):699-702. PubMed ID: 38289804
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
17. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
18. [Pregnancy related cervical cytological changes and clinical management].
Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
[TBL] [Abstract][Full Text] [Related]
19. Results of Further Diagnostic Procedures Among Patients with Cytological Characteristics of Minor Changes on Pap Smears.
Kacperczyk J; Bartnik P; Romejko-Wolniewicz E; Jalinik K
Anticancer Res; 2016 Mar; 36(3):1023-6. PubMed ID: 26976993
[TBL] [Abstract][Full Text] [Related]
20. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
